148 related articles for article (PubMed ID: 20025498)
1. Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
Kuan CT; Wikstrand CJ; McLendon RE; Zalutsky MR; Kumar U; Bigner DD
Hybridoma (Larchmt); 2009 Dec; 28(6):389-403. PubMed ID: 20025498
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts.
He XM; Skapek SX; Wikstrand CJ; Friedman HS; Trojanowski JQ; Kemshead JT; Coakham HB; Bigner SH; Bigner DD
J Neuropathol Exp Neurol; 1989 Jan; 48(1):48-68. PubMed ID: 2535715
[TBL] [Abstract][Full Text] [Related]
3. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.
Frühwald MC; O'Dorisio MS; Pietsch T; Reubi JC
Pediatr Res; 1999 May; 45(5 Pt 1):697-708. PubMed ID: 10231868
[TBL] [Abstract][Full Text] [Related]
4. Phosphate-dependent and independent neurofilament protein epitopes are expressed throughout the cell cycle in human medulloblastoma (D283 MED) cells.
Trojanowski JQ; Kelsten ML; Lee VM
Am J Pathol; 1989 Oct; 135(4):747-58. PubMed ID: 2478022
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.
Ise T; Maeda H; Santora K; Xiang L; Kreitman RJ; Pastan I; Nagata S
Clin Cancer Res; 2005 Jan; 11(1):87-96. PubMed ID: 15671532
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of somatostatin receptors in medulloblastoma.
Guyotat J; Champier J; Pierre GS; Jouvet A; Bret P; Brisson C; Belin MF; Signorelli F; Montange MF
J Neurooncol; 2001 Jan; 51(2):93-103. PubMed ID: 11386415
[TBL] [Abstract][Full Text] [Related]
7. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
Li XN; Parikh S; Shu Q; Jung HL; Chow CW; Perlaky L; Leung HC; Su J; Blaney S; Lau CC
Clin Cancer Res; 2004 Feb; 10(3):1150-9. PubMed ID: 14871995
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.
Meco D; Servidei T; Riccardi A; Ferlini C; Cusano G; Zannoni GF; Giangaspero F; Riccardi R
Neuro Oncol; 2009 Jun; 11(3):250-9. PubMed ID: 19033425
[TBL] [Abstract][Full Text] [Related]
9. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
Bacolod MD; Lin SM; Johnson SP; Bullock NS; Colvin M; Bigner DD; Friedman HS
Curr Cancer Drug Targets; 2008 May; 8(3):172-9. PubMed ID: 18473730
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
Ritz R; Scheidle C; Noell S; Roser F; Schenk M; Dietz K; Strauss WS
PLoS One; 2012; 7(12):e51974. PubMed ID: 23251668
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.
Nicholson LB; Vlase H; Graves P; Nilsson M; Molne J; Huang GC; Morgenthaler NG; Davies TF; McGregor AM; Banga JP
J Mol Endocrinol; 1996 Apr; 16(2):159-70. PubMed ID: 9156519
[TBL] [Abstract][Full Text] [Related]
12. The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
Thompson EM; Whitney NL; Wu YJ; Neuwelt EA
J Neurosurg Pediatr; 2013 Jan; 11(1):60-7. PubMed ID: 23082872
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA.
Hung AF; Chen JB; Lu CS; Chen NY; Yu HM; Chang TW
Mol Immunol; 2011 Sep; 48(15-16):1975-82. PubMed ID: 21723611
[TBL] [Abstract][Full Text] [Related]
14. Differential role for protein kinase C-mediated signaling in the proliferation of medulloblastoma cell lines.
Adesina AM; Dooley N; Yong VW; Nalbantoglu J
Int J Oncol; 1998 Apr; 12(4):759-68. PubMed ID: 9499434
[TBL] [Abstract][Full Text] [Related]
15. Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines.
He XM; Ostrowski LE; von Wronski MA; Friedman HS; Wikstrand CJ; Bigner SH; Rasheed A; Batra SK; Mitra S; Brent TP
Cancer Res; 1992 Mar; 52(5):1144-8. PubMed ID: 1737373
[TBL] [Abstract][Full Text] [Related]
16. Activation of complement by monoclonal antibodies that target cell-associated β₂-microglobulin: implications for cancer immunotherapy.
Pokrass MJ; Liu MF; Lindorfer MA; Taylor RP
Mol Immunol; 2013 Dec; 56(4):549-60. PubMed ID: 23911412
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Wikstrand CJ; Hale LP; Batra SK; Hill ML; Humphrey PA; Kurpad SN; McLendon RE; Moscatello D; Pegram CN; Reist CJ
Cancer Res; 1995 Jul; 55(14):3140-8. PubMed ID: 7606735
[TBL] [Abstract][Full Text] [Related]
18. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
19. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.
Leu FP; Nandi M
Pancreas; 2010 Nov; 39(8):1155-66. PubMed ID: 20531241
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and epitope analysis of monoclonal antibodies to virions of clover yellow vein and Johnsongrass mosaic potyviruses.
Hewish DR; Xiao XW; Mishra A; Gough KH; Shukla DD
Arch Virol; 1993; 133(1-2):127-41. PubMed ID: 7694567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
